Latest news with #KeirInternational
Yahoo
19-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Under US$400M
As Gulf bourses display mixed results, with investors on the lookout for new catalysts amid fluctuating oil prices and shifting global trade dynamics, attention turns to the potential of smaller market players. Penny stocks, a term that may seem outdated, still hold relevance as they often represent smaller or newer companies with significant growth potential. This article will explore three such stocks from the Middle East that combine financial strength with promising opportunities for investors seeking hidden value. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.17 SAR1.67B ★★★★★★ Keir International (SASE:9542) SAR3.95 SAR474M ★★★★★☆ Alarum Technologies (TASE:ALAR) ₪2.797 ₪195.88M ★★★★★★ Terminal X Online (TASE:TRX) ₪4.535 ₪575.97M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.927 ₪2.88B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.207 ₪164.07M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.701 AED426.39M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED2.88 AED332.64M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.00 AED2.02B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.38 AED10.03B ★★★★☆☆ Click here to see the full list of 93 stocks from our Middle Eastern Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Gulf Pharmaceutical Industries P.S.C., along with its subsidiaries, operates in the manufacturing and sale of medicines, drugs, and various pharmaceutical, cosmetic, and medical compounds across the United Arab Emirates, other GCC countries, and internationally with a market cap of AED1.59 billion. Operations: The company's revenue is primarily derived from its Manufacturing segment, which generated AED864.9 million, and its Planet segment, contributing AED732.9 million. Market Cap: AED1.59B Gulf Pharmaceutical Industries P.S.C. has demonstrated significant financial improvement, becoming profitable over the past year with a net income of AED 140.9 million in Q1 2025, up from AED 1.9 million the previous year. The company maintains strong short-term asset coverage over both its short and long-term liabilities, and its debt is well managed with a satisfactory net debt to equity ratio of 4.8%. Despite low return on equity at 2.4%, earnings quality remains high, supported by stable weekly volatility and reduced debt levels from previous years, reflecting prudent financial management amidst growing revenues forecasted at 6.91% annually. Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here. Understand Gulf Pharmaceutical Industries P.S.C's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat in 2006 and transformed into a Real Estate Investment Partnership in 2007, operates in the real estate sector with a market capitalization of TRY15.08 billion. Operations: The company generates revenue of TRY13.44 billion from its residential real estate developments segment. Market Cap: TRY15.08B Sinpas Gayrimenkul Yatirim Ortakligi has shown impressive earnings growth, with a 210.1% increase over the past year, outpacing its five-year average of 33.4%. The company's debt management is robust, evidenced by a net debt to equity ratio of 11.1%, and its operating cash flow comfortably covers debt obligations at 33.3%. However, interest coverage remains a concern at only 2.3 times EBIT. Despite large one-off gains impacting recent financial results and declining profit margins from last year, the company trades at an attractive price-to-earnings ratio of 2.9x compared to the broader market's 19.1x. Dive into the specifics of Sinpas Gayrimenkul Yatirim Ortakligi here with our thorough balance sheet health report. Examine Sinpas Gayrimenkul Yatirim Ortakligi's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Alarum Technologies Ltd. offers web data collection solutions across multiple regions including the Americas, Europe, Southeast Asia, the Middle East, and Africa, with a market cap of ₪195.88 million. Operations: Alarum Technologies generates revenue from web data collection ($30.91 million), advertising services ($0.04 million), and consumer internet access ($0.87 million). Market Cap: ₪195.88M Alarum Technologies, with a market cap of ₪195.88 million, has demonstrated profitability with earnings of US$5.78 million for 2024, rebounding from a previous net loss. Its revenue streams are diversified across web data collection and consumer internet access. The company's debt management is strong, with cash exceeding total debt and operating cash flow covering debt by over 900%. However, the stock remains highly volatile and faces legal challenges due to a class action lawsuit in the U.S., which could impact investor sentiment despite its solid financial footing and high return on equity at 21.9%. Unlock comprehensive insights into our analysis of Alarum Technologies stock in this financial health report. Assess Alarum Technologies' future earnings estimates with our detailed growth reports. Access the full spectrum of 93 Middle Eastern Penny Stocks by clicking on this link. Ready For A Different Approach? Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ALAR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$60M To Watch
As the Middle Eastern markets navigate the complexities of global trade tensions, particularly between the U.S. and China, investors are keeping a close eye on regional indices that have shown mixed performances. In this context, penny stocks—though an older term—continue to represent smaller or less-established companies that might offer significant value to discerning investors. By focusing on those with solid financials and growth potential, these stocks can provide unique opportunities for those looking beyond traditional investment options. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪0.999 ₪123.04M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.446 ₪171.3M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.922 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.709 AED425.78M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.40 AED390.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.1B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Yayin Holding A.S. operates in Turkey through its subsidiaries, focusing on media, publishing, and advertising businesses with a market cap of TRY940.50 million. Operations: The company generates revenue from several segments, including Journalism and Printing Works (TRY1.77 billion), News Agencies (TRY389.08 million), and TV Services and Other (TRY318.35 million). Market Cap: TRY940.5M Ihlas Yayin Holding's financial landscape presents a mixed picture for investors considering penny stocks. The company's revenue of TRY2.48 billion reflects a slight decline from the previous year, while it remains unprofitable with a net loss of TRY227.23 million. Despite this, the company has more cash than debt and its short-term assets exceed short-term liabilities, indicating some financial resilience. However, its cash runway is less than one year if free cash flow continues to shrink at historical rates. The board's average tenure of 5.3 years suggests experienced governance amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Ihlas Yayin Holding. Gain insights into Ihlas Yayin Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Metro Ticari ve Mali Yatirimlar Holding A.S. operates as a diversified holding company with various business interests, and it has a market capitalization of TRY1.33 billion. Operations: The company generates revenue primarily from its Transportation - Railroads segment, amounting to TRY28.73 million. Market Cap: TRY1.33B Metro Ticari ve Mali Yatirimlar Holding, with a market cap of TRY1.33 billion, operates without debt and has not diluted shareholders recently. Despite generating TRY28.73 million in revenue primarily from its railroads segment, the company remains unprofitable with a significant net loss of TRY1,085.84 million for the past year. Its short-term assets exceed liabilities but fall short against long-term obligations of TRY219.6 million. The firm boasts a cash runway exceeding three years if current free cash flow remains stable, supported by an experienced board averaging 4.8 years in tenure amidst financial challenges and volatility stability over the past year. Unlock comprehensive insights into our analysis of Metro Ticari ve Mali Yatirimlar Holding stock in this financial health report. Assess Metro Ticari ve Mali Yatirimlar Holding's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪230.08 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪230.08M Bonus BioGroup Ltd., with a market cap of ₪230.08 million, is a pre-revenue clinical-stage biotechnology company focusing on tissue engineering and cell therapy products. The firm recently secured FDA clearance for a Phase III clinical study of MesenCure™, targeting respiratory distress in severely ill patients. Despite its potential, the company faces financial challenges, including short-term assets that do not cover liabilities and a cash runway limited to three months before recent capital raising efforts. While debt-free and led by an experienced management team, Bonus BioGroup's stock remains highly volatile with no significant revenue streams yet established. Click here and access our complete financial health analysis report to understand the dynamics of Bonus BioGroup. Gain insights into Bonus BioGroup's past trends and performance with our report on the company's historical track record. Gain an insight into the universe of 95 Middle Eastern Penny Stocks by clicking here. Curious About Other Options? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IHYAY IBSE:METRO and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-05-2025
- Business
- Yahoo
Middle Eastern Penny Stocks With Market Caps Over US$60M To Watch
As the Middle Eastern markets navigate the complexities of global trade tensions, particularly between the U.S. and China, investors are keeping a close eye on regional indices that have shown mixed performances. In this context, penny stocks—though an older term—continue to represent smaller or less-established companies that might offer significant value to discerning investors. By focusing on those with solid financials and growth potential, these stocks can provide unique opportunities for those looking beyond traditional investment options. Name Share Price Market Cap Financial Health Rating Thob Al Aseel (SASE:4012) SAR4.13 SAR1.58B ★★★★★★ Keir International (SASE:9542) SAR3.92 SAR474M ★★★★★☆ Dna Group (T.R.) (TASE:DNA) ₪0.999 ₪123.04M ★★★★★★ Alarum Technologies (TASE:ALAR) ₪2.446 ₪171.3M ★★★★★★ Oil Refineries (TASE:ORL) ₪0.922 ₪2.87B ★★★★★☆ Tgi Infrastructures (TASE:TGI) ₪2.222 ₪165.19M ★★★★★★ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.709 AED425.78M ★★★★★★ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.40 AED390.39M ★★★★★★ E7 Group PJSC (ADX:E7) AED1.03 AED2.1B ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.36 AED10.03B ★★★★☆☆ Click here to see the full list of 95 stocks from our Middle Eastern Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Ihlas Yayin Holding A.S. operates in Turkey through its subsidiaries, focusing on media, publishing, and advertising businesses with a market cap of TRY940.50 million. Operations: The company generates revenue from several segments, including Journalism and Printing Works (TRY1.77 billion), News Agencies (TRY389.08 million), and TV Services and Other (TRY318.35 million). Market Cap: TRY940.5M Ihlas Yayin Holding's financial landscape presents a mixed picture for investors considering penny stocks. The company's revenue of TRY2.48 billion reflects a slight decline from the previous year, while it remains unprofitable with a net loss of TRY227.23 million. Despite this, the company has more cash than debt and its short-term assets exceed short-term liabilities, indicating some financial resilience. However, its cash runway is less than one year if free cash flow continues to shrink at historical rates. The board's average tenure of 5.3 years suggests experienced governance amidst these challenges. Jump into the full analysis health report here for a deeper understanding of Ihlas Yayin Holding. Gain insights into Ihlas Yayin Holding's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Metro Ticari ve Mali Yatirimlar Holding A.S. operates as a diversified holding company with various business interests, and it has a market capitalization of TRY1.33 billion. Operations: The company generates revenue primarily from its Transportation - Railroads segment, amounting to TRY28.73 million. Market Cap: TRY1.33B Metro Ticari ve Mali Yatirimlar Holding, with a market cap of TRY1.33 billion, operates without debt and has not diluted shareholders recently. Despite generating TRY28.73 million in revenue primarily from its railroads segment, the company remains unprofitable with a significant net loss of TRY1,085.84 million for the past year. Its short-term assets exceed liabilities but fall short against long-term obligations of TRY219.6 million. The firm boasts a cash runway exceeding three years if current free cash flow remains stable, supported by an experienced board averaging 4.8 years in tenure amidst financial challenges and volatility stability over the past year. Unlock comprehensive insights into our analysis of Metro Ticari ve Mali Yatirimlar Holding stock in this financial health report. Assess Metro Ticari ve Mali Yatirimlar Holding's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Bonus BioGroup Ltd. is a clinical-stage biotechnology company focused on developing tissue engineering and cell therapy products, with a market cap of ₪230.08 million. Operations: Bonus BioGroup Ltd. currently has no reported revenue segments. Market Cap: ₪230.08M Bonus BioGroup Ltd., with a market cap of ₪230.08 million, is a pre-revenue clinical-stage biotechnology company focusing on tissue engineering and cell therapy products. The firm recently secured FDA clearance for a Phase III clinical study of MesenCure™, targeting respiratory distress in severely ill patients. Despite its potential, the company faces financial challenges, including short-term assets that do not cover liabilities and a cash runway limited to three months before recent capital raising efforts. While debt-free and led by an experienced management team, Bonus BioGroup's stock remains highly volatile with no significant revenue streams yet established. Click here and access our complete financial health analysis report to understand the dynamics of Bonus BioGroup. Gain insights into Bonus BioGroup's past trends and performance with our report on the company's historical track record. Gain an insight into the universe of 95 Middle Eastern Penny Stocks by clicking here. Curious About Other Options? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IHYAY IBSE:METRO and TASE:BONS. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
